Sec Form 13D Filing - Deep Track Capital, LP filing for Dynavax Technologies Corporation (DVAX) - 2025-02-19

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
Deep Track Biotechnology Master Fund, Ltd.
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Director
Date:02/19/2025
 
Deep Track Capital, LP
 
Signature:/s/ David Kroin
Name/Title:David Kroin, Managing Member of the General Partner of Deep Track Capital, LP
Date:02/19/2025
 
David Kroin
 
Signature:/s/ David Kroin
Name/Title:David Kroin
Date:02/19/2025
Comments accompanying signature:
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifi es that the information set forth in this statement is true, complete and correct.
primary_doc.xml